{"schema_version":"secwatch.filing_event.v1","accession":"0001656472-23-000124","form_type":"8-K","ticker":"CRON","cik":"0001656472","company_name":"Cronos Group Inc.","filed_at":"2023-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.736829+00:00","generated_at":"2026-06-12T02:13:30.837160+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cronos Group Q2 revenue down 12% to $19M, withdraws FY2023 guidance; announces facility wind-down","bullets":["Q2 net revenue $19.0M (-12% YoY); net loss improved to $(5.7)M from $(17.5)M YoY.","Withdrew FY2023 net revenue target of $100-110M citing political unrest in Israel and competitive activity.","Operating expense savings target raised to $20-25M; planning wind-down of Cronos Fermentation facility by end of 2023.","Cash and short-term investments $841M; net cash decline for H2 2023 expected less than $5-10M (improved guidance).","Expects incremental $10-15M savings in 2024 from additional expense reductions and facility exit."],"urls":{"canonical":"https://secwatch.observer/filing/0001656472-23-000124","json":"https://secwatch.observer/filing/0001656472-23-000124.json","markdown":"https://secwatch.observer/filing/0001656472-23-000124.md","text":"https://secwatch.observer/filing/0001656472-23-000124.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1656472/000165647223000124/0001656472-23-000124-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1656472/000165647223000124/cron-20230808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T02:13:30.837160+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3ba44d2c0e3453cbbb0f2127ac6dab5b865d0a37","claim":"Cronos Group Inc. reported second quarter ended June 30, 2023 results: revenue $19.0 million, net income $(5.7) million. Guidance lowered.","evidence_excerpt":"of investing activities and is defined as the sum of purchase of property, plant and equipment, and purchase of intangible assets. Second Quarter 2023 • Net revenue of $19.0 million in Q2 2023 decreased by $2.6 million from Q2 2022. The decrease was primarily due to lower cannabis flower sales in Israel due to competitive activity, the slowdown in patient","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1656472/000165647223000124/0001656472-23-000124-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Revenue","value":"$19.0 million"},{"label":"Net income","value":"$(5.7) million"},{"label":"Guidance","value":"lowered"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}